Quantcast
Last updated on April 16, 2014 at 0:13 EDT

Latest proteomics Stories

2013-11-20 08:28:39

ROCKVILLE, Md., Nov. 20, 2013 /PRNewswire/ -- OncoPlex Diagnostics a CAP-accredited, CLIA-certified cancer diagnostics laboratory providing clinical proteomics and genomics supporting personalized patient care announced the appointment of Dr. Jedd Levine to the position of Chief Medical Officer. Dr. Levine will report to the CEO, Jon Burrows, Ph.D., in the role. The appointment of Dr. Levine adds an increased level of clinical oncology expertise to OncoPlexDx. (Logo:...

2013-11-19 23:25:01

The Quarterly Online Seminar Series Starts with Advanced Genomics in Clinical and Translational Research, November 20, 2013. Yorba Linda, CA (PRWEB) November 19, 2013 Life Technologies has developed a new online seminar series to help researchers and clinicians stay updated on the most recent developments in science. These quarterly events will focus on topics in translational research and clinical diagnostics including pharmacogenomics, infectious disease, advances in cancer research,...

2013-11-19 08:27:59

SAN DIEGO, Nov. 19, 2013 /PRNewswire/ -- Applied Proteomics Inc. (API), the leading developer of protein-based molecular diagnostics, announces the appointment of Premal S. Shah, Ph.D., as vice president of business development. Dr. Shah was previously director of business development at Genomic Health, where he was responsible for driving go-to-market strategies and establishing key collaborations with pharmaceutical companies for joint biomarker discovery ventures. "API is...

Researchers Exploit Power Of Evolution To Create Designer Proteins
2013-11-15 10:18:45

University of Leicester An international team of researchers led by the University of Leicester has "harnessed the power of evolution" to create a new drug for possible use against heart disease, inflammation and other illnesses. Researchers in the Department of Cardiovascular Sciences and Department of Biochemistry at the University of Leicester, together with colleagues in Cambridge, the USA and Italy, have employed a new technique to create protein-based drugs. According to...

2013-11-14 16:25:32

DUBLIN, November 14, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/ftn84k/proteomics ) has announced the addition of the "Proteomics - Global Strategic Business Report" [http://www.researchandmarkets.com/research/ftn84k/proteomics ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report analyzes the worldwide markets for Proteomics...

2013-11-14 08:34:50

Metabolon to Conduct Biochemical Profiling in Single Largest Prospective Pan-Omic Study RICHMOND, Va. and RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2013 /PRNewswire/ -- Global Genomics Group (G3) and Metabolon today announced that they have entered into a collaboration agreement to investigate biological networks and pathways in order to discover novel biomarkers and pharmaceutical targets for cardiovascular diseases. Under the terms of the agreement, Metabolon will analyze the...

2013-11-01 08:25:12

DUBLIN, November 1, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/p37ckx/proteomics_market) has announced the addition of the "Proteomics Market (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation, X-ray Crystallography, Immunoassay) - Instruments, Reagents and Services - Trends and Globa"...

2013-10-17 08:29:09

Series A investors include 5AM Ventures, Pfizer Venture Investments and Roche Venture Fund BURLINGAME, Calif., Oct. 17, 2013 /PRNewswire/ -- Biodesy, Inc., a privately held developer of novel systems to analyze real-time protein function for research and clinical applications, announced today that it has closed a $15.0 million Series A venture financing round from 5AM Ventures, Pfizer Venture Investments and Roche Venture Fund. In addition, Greg Yap has been named Chief Executive...

2013-10-16 16:25:45

Breakthrough Technology Powered by Advanced MRM-Mass Spec Protein Detection Provides Scientific Validation of Caprion's Proteomics Biomarker Discovery Technologies and Partnership-Driven Business Model MONTREAL, Oct. 16, 2013 /PRNewswire/ - Caprion Proteomics announced today the results of a major study conducted by Indi (Integrated Diagnostics), an emerging leader in molecular diagnostics that has been actively collaborating with Caprion since 2008, which suggests that...

2013-10-09 16:22:35

ReportsnReports.com offers Analysis of Global Biochips Industry, 2012-2018 market research report that reviews the latest biochips market trends with a perceptive attempt to disclose the near-future growth prospects. DALLAS, Oct. 9, 2013 /PRNewswire-iReach/ -- Analysis of Global Biochips Industry, 2012-2018 market research report forecasts the global biochips market to reach US$11.4 billion by 2018 with a CAGR of 18.6% during 2012-2018; the massive CAGR is primarily supported by Asia-Pacific...